Post Listing Comment on Medplus IPO By Mr. Santosh Meena, Swastika Investmart Ltd

24/12/2021 11:39:51 AM | Source: Swastika Investmart Ltd

Post Listing Comment on Medplus IPO By Mr. Santosh Meena, Swastika Investmart Ltd

News By Tags | #607 #442 #7101 #5503 #2911

Below is the Post Listing Comment on Medplus IPO by Mr. Santosh Meena, Head of Research, Swastika Investmart Ltd

The IPO was subscribed 52 times and debuted at Rs 1040 per share as opposed to the issue price of Rs 796, a 30% premium. Long-term investors should hold the stock and it might turn into a wealth creator in the next 2-3 years, however, short-term investors are advised to keep an SL of Rs 875. MedPlus has an omnichannel platform and is the second-largest pharmacy retailer. We believe the growth opportunities from the industry will justify the company's valuation in the long run, even if it appeared to be expensive at first glance.

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here

IGI Logo

Post Listing Comment on Medplus IPO By Mr. Santosh Meena, Swastika Investmart Ltd

Top News

Tag News

More News